טוען...
Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?
SIMPLE SUMMARY: This work aims to discuss how an anti- or pro-tumor immune response could be manipulated through immune checkpoint blockade in patients with early stage HER2-positive breast cancer. By summarizing previously published evidence in the field, authors present their personal view on how...
שמור ב:
| הוצא לאור ב: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036848/ https://ncbi.nlm.nih.gov/pubmed/33916115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071655 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|